English
Русский
简体中文
Português (Brasil)
Kazakh
Eco-vector
Pharmateca
ISSN 2073-4034 (Print) ISSN 2414-9128 (Online)
Menu     Archives
  • Home
  • About the Journal
    • Editorial Policies
    • Author Guidelines
    • About the Journal
  • Issues
    • Search
    • Current
    • Retracted articles
    • Archives
  • Contact
  • Subscriptions
  • Editorial Board
  • All Journals
User
Forgot password? Register
Notifications
  • View
  • Subscribe
Subscription Login to verify subscription
Search
Browse
  • By Issue
  • By Author
  • By Title
  • Other Journals
  • Categories
Keywords COVID-19 Helicobacter pylori arterial hypertension atopic dermatitis breast cancer bronchial asthma chemotherapy children chronic obstructive pulmonary disease diabetes mellitus insulin resistance metabolic syndrome non-steroidal anti-inflammatory drugs obesity osteoporosis pregnancy probiotics stroke treatment type 2 diabetes mellitus vitamin D
×
User
Forgot password? Register
Notifications
  • View
  • Subscribe
Subscription Login to verify subscription
Search
Browse
  • By Issue
  • By Author
  • By Title
  • Other Journals
  • Categories
Keywords COVID-19 Helicobacter pylori arterial hypertension atopic dermatitis breast cancer bronchial asthma chemotherapy children chronic obstructive pulmonary disease diabetes mellitus insulin resistance metabolic syndrome non-steroidal anti-inflammatory drugs obesity osteoporosis pregnancy probiotics stroke treatment type 2 diabetes mellitus vitamin D
Home > Search > Author Details

Author Details

Ганьшина, И. П

Issue Section Title File
No 8 (2014) Articles DVOYNAYa BLOKADA HER2-PETsEPTOPA - NOVOE NAPRAVLENIE V LEChENII RAKA MOLOChNOY ZhELEZY S GIPEREKSPRESSIEY HER2
No 17 (2014) Articles Pertuzumab - novyy vzglyad na HER2-polozhitel'nyy metastaticheskiy rak molochnoy zhelezy
No 8 (2016) Articles PLACE OF LAPATINIB IN THE THERAPY OF HER2-POSITIVE BREAST CANCER
Vol 28, No 7 (2021) Articles Abemacyclib is a unique representative of the class of CDK4/6 inhibitors in the treatment of HR+/HER2- metastatic breast cancer
Vol 28, No 7 (2021) Articles Dermatological toxity of alpelisib: clinical experience and review of current guidelines
Vol 28, No 7 (2021) Articles Olaparib -modern approach to the treatment of BRCA-associated HER2-negative metastatic breast cancer. Clinical experience
Vol 28, No 11 (2021) Articles Dual HER2 blockade with pertuzumab+trastuzumab on the eve of a new era in the treatment of HER2-positive breast cancer
 

 

Developed by ECO-VECTOR

 

Powered by EVESYST

TOP